You just read:

Data Presented at AACE 2017 Annual Meeting Demonstrate Long-Term Clinical Utility Of Veracyte's Afirma® Gene Expression Classifier in Thyroid Cancer Diagnosis

News provided by

Veracyte

08 May, 2017, 08:00 ET